Estrella Immunopharma Inc...
(ESLA)
undefined
undefined%
At close: undefined
1.19
0.00%
After-hours Jan 07, 2025, 03:59 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 |
| Net Income | -7.31M | -996.10K | -1.69M | -733.69K |
| Depreciation & Amortization | n/a | n/a | n/a | n/a |
| Stock-Based Compensation | 1.19M | n/a | 129.97K | 62.87K |
| Other Working Capital | -618.09K | 576.86K | 113.35K | n/a |
| Other Non-Cash Items | n/a | -654.07K | -1.43K | n/a |
| Deferred Income Tax | n/a | 29.47K | n/a | n/a |
| Change in Working Capital | -9.95M | 576.86K | 113.35K | n/a |
| Operating Cash Flow | -16.07M | -1.04M | -1.44M | -670.82K |
| Capital Expenditures | -4 | n/a | n/a | n/a |
| Acquisitions | n/a | n/a | n/a | n/a |
| Purchase of Investments | n/a | n/a | -45.19M | n/a |
| Sales Maturities Of Investments | n/a | 36.17M | n/a | n/a |
| Other Investing Acitivies | 4.96M | n/a | n/a | n/a |
| Investing Cash Flow | 4.96M | 36.17M | -45.19M | n/a |
| Debt Repayment | n/a | 498.60K | n/a | n/a |
| Common Stock Repurchased | -354.44K | -36.11M | -25.00K | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 13.15M | 50.00K | 5.53M | 670.82K |
| Financial Cash Flow | 12.79M | -35.56M | 5.53M | 670.82K |
| Net Cash Flow | 1.69M | -438.07K | 4.09M | n/a |
| Free Cash Flow | -16.07M | -1.04M | -1.44M | -670.82K |